無料プレビュー

Bausch Health Companies Inc. (BHC) · New York Stock Exchange

プロフィール

Bausch Health Companies Inc. is a global diversified specialty pharmaceutical and medical device company that develops, manufactures and markets branded, generic and over-the-counter pharmaceuticals, aesthetic medical devices, and eye health products including contact lenses, intraocular lenses and ophthalmic surgical equipment through a substantial ownership stake in Bausch + Lomb Corporation. Primary therapeutic areas include gastroenterology, hepatology, neurology, dermatology and eye health, with products marketed across multiple countries through five reportable segments: Salix, Internati

主要指標

株価: $6.04 (-1.79%)
時価総額: 23億ドル
PER（今期予想）: 1.3
PBR: -1.3
配当利回り: —
52週レンジ: $4.33 – $8.00
業種: Healthcare / Drug Manufacturers - Specialty & Generic
上場: New York Stock Exchange
構成銘柄: —

比較会社: TAK Takeda Pharmaceutical Company Limited、TEVA Teva Pharmaceutical Industries Limited、HLN Haleon plc、ZTS Zoetis Inc.、VTRS Viatris Inc.、ITCI Intra-Cellular Therapies, Inc.、CTLT Catalent, Inc.、ELAN Elanco Animal Health Incorporated

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-10-28 · 更新: 2026-10-09